423 A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer by Lawrence Fong, Russell Pachynski, Peter Oppelt, Melissa Reimers, Cody Weimholt, Katie Slane, Jason Frankel, Robert Figenshau, Eric Kim, Gerald Andriole